Clinical Trial Update: SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SU5416 for AIDS-related Kaposi's sarcoma has completed, sponsored by the AIDS Malignancy Consortium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• SU5416 (semaxanib)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Sarcoma | Phase 2 | Status: COMPLETED